| Eli Lilly And Company | 420K | US$464M | 8.0% |
| Danaher Corporation | 2.18M | US$398M | 6.9% |
| Johnson & Johnson | 1.26M | US$284M | 4.9% |
| Thermo Fisher Scientific Inc | 508K | US$250M | 4.3% |
| Unitedhealth Group Incorporated | 530K | US$202M | 3.5% |
| Alnylam Pharmaceuticals, Inc. | 460K | US$139M | 2.4% |
| Gilead Sciences, Inc. | 950K | US$128M | 2.2% |
| Boston Scientific Corporation | 2.6M | US$126M | 2.2% |
| Ascendis Pharma A/s | 560K | US$126M | 2.2% |
| Abbvie Inc. | 540K | US$118M | 2.0% |
| Ucb S.a. | 400K | US$117M | 2.0% |
| Bio-techne Corp | 1.9M | US$98.2M | 1.7% |
| Merck & Company, Inc. | 780K | US$92.6M | 1.6% |
| Argenx Se | 108K | US$90.3M | 1.6% |
| Cvs Health Corporation | 820K | US$74.6M | 1.3% |
| Nuvalent, Inc. | 670K | US$74M | 1.3% |
| Natera, Inc. | 328K | US$73.3M | 1.3% |
| Brightspring Health Services, Inc. | 1.15M | US$70.9M | 1.2% |
| Viatris Inc. | 4.28M | US$69.6M | 1.2% |
| Moderna, Inc. | 1.45M | US$68.4M | 1.2% |
| Cencora, Inc. | 245K | US$66M | 1.1% |
| West Pharmaceutical Services, Inc. | 200K | US$64.6M | 1.1% |
| Agilent Technologies, Inc. | 471K | US$63.8M | 1.1% |
| Edwards Lifesciences Corporation | 728K | US$63M | 1.1% |
| Xenon Pharmaceuticals Inc. | 1.15M | US$62.9M | 1.1% |
| Caris Life Sciences, Inc. | 3.75M | US$62.7M | 1.1% |
| Royalty Pharma Plc | 1.12M | US$62.5M | 1.1% |
| Cogent Biosciences, Inc. | 1.75M | US$61.2M | 1.1% |
| Guardant Health, Inc. | 460K | US$59.7M | 1.0% |
| Vaxcyte, Inc. | 1.16M | US$59.6M | 1.0% |
| Veracyte, Inc. | 1.28M | US$59.3M | 1.0% |
| Repligen Corporation | 460K | US$57M | 0.99% |
| Spyre Therapeutics, Inc. | 760K | US$55.9M | 0.97% |
| Jazz Pharmaceuticals Plc | 235K | US$55.6M | 0.96% |
| Revolution Medicines, Inc. | 350K | US$55.1M | 0.95% |
| Roche Holding Ltd | 128K | US$54M | 0.93% |
| Privia Health Group, Inc. | 2.5M | US$53.8M | 0.93% |
| Insmed Incorporated | 500K | US$53.5M | 0.92% |
| Bruker Corporation | 850K | US$50.1M | 0.87% |
| Oruka Therapeutics, Inc. | 833K | US$48.8M | 0.84% |
| 10x Genomics, Inc. | 1.6M | US$45.3M | 0.78% |
| Axsome Therapeutics, Inc. | 190K | US$44.6M | 0.77% |
| Enliven Therapeutics, Inc. | 1.12M | US$44.3M | 0.77% |
| Elevance Health, Inc. | 110K | US$43.3M | 0.75% |
| Crinetics Pharmaceuticals, Inc. | 1.2M | US$42.7M | 0.74% |
| Kiniksa Pharmaceuticals International, Plc | 845K | US$40.9M | 0.71% |
| Alignment Healthcare, Inc. | 2.6M | US$39.8M | 0.69% |
| Lifestance Health Group, Inc. | 4.98M | US$38.4M | 0.66% |
| Roivant Sciences Ltd. | 1.28M | US$38.4M | 0.66% |
| Mineralys Therapeutics, Inc. | 1.18M | US$37.2M | 0.64% |
| Kymera Therapeutics, Inc. | 450K | US$36.6M | 0.63% |
| Medline Inc. | 1M | US$36.6M | 0.63% |
| Praxis Precision Medicines, Inc. | 100K | US$35M | 0.61% |
| Intuitive Surgical, Inc. | 75,000 | US$31.8M | 0.55% |
| Disc Medicine, Inc. | 450K | US$31.3M | 0.54% |
| Cg Oncology, Inc. | 500K | US$31.1M | 0.54% |
| Heartflow, Inc. | 1M | US$31M | 0.54% |
| Biogen Inc. | 150K | US$29.4M | 0.51% |
| Travere Therapeutics, Inc. | 570K | US$26.9M | 0.47% |
| Sartorius Stedim Biotech Sa | 128K | US$26.6M | 0.46% |
| Viridian Therapeutics, Inc. | 1.5M | US$26.4M | 0.46% |
| Beone Medicines Ltd. Class A | 90,000 | US$25.9M | 0.45% |
| Pharvaris N.v. | 800K | US$24.1M | 0.42% |
| Relay Therapeutics, Inc. | 1.68M | US$23.6M | 0.41% |
| Newamsterdam Pharma Company N.v. | 690K | US$23.2M | 0.40% |
| Mirum Pharmaceuticals, Inc. | 220K | US$22.3M | 0.39% |
| Waystar Holding Corp. | 1.08M | US$21.5M | 0.37% |
| Scholar Rock Holding Corporation | 430K | US$21.2M | 0.37% |
| Irhythm Holdings, Inc. | 180K | US$20.5M | 0.35% |
| Amylyx Pharmaceuticals, Inc. | 1.42M | US$20.4M | 0.35% |
| Zenas Biopharma, Inc. | 1.08M | US$19.9M | 0.34% |
| Olema Pharmaceuticals, Inc. | 1.5M | US$19.8M | 0.34% |
| Stoke Therapeutics, Inc. | 628K | US$19.4M | 0.34% |
| Dianthus Therapeutics, Inc. | 207K | US$19.3M | 0.33% |
| Kestra Medical Technologies, Ltd. | 900K | US$19.1M | 0.33% |
| Mbx Biosciences, Inc. | 600K | US$18.9M | 0.33% |
| Veradermics, Incorporated | 180K | US$18.2M | 0.31% |
| Cytomx Therapeutics, Inc. | 5M | US$18M | 0.31% |
| Viking Therapeutics, Inc. | 540K | US$17.7M | 0.31% |
| Insulet Corporation | 100K | US$14.5M | 0.25% |
| Trevi Therapeutics, Inc. | 1M | US$14.1M | 0.24% |
| Summit Therapeutics Inc. | 800K | US$14M | 0.24% |
| Jade Biosciences, Inc. | 640K | US$13.5M | 0.23% |
| Damora Therapeutics, Inc. | 500K | US$12.4M | 0.22% |
| Gmr Solutions Inc. | 994K | US$12.4M | 0.21% |
| Edgewise Therapeutics, Inc. | 294K | US$10M | 0.17% |
| Tyra Biosciences, Inc. | 280K | US$9.35M | 0.16% |
| Shoulder Innovations, Inc. | 545K | US$8.02M | 0.14% |
| Outset Medical, Inc. | 1.52M | US$7.43M | 0.13% |
| Apogee Therapeutics, Inc. | 90,007 | US$7.39M | 0.13% |
| Upstream Bio, Inc. | 800K | US$6.69M | 0.12% |
| Alumis Inc. | 301K | US$6.51M | 0.11% |
| Annexon, Inc. | 1.2M | US$6.5M | 0.11% |
| First Tracks Biotherapeutics, Inc. | 400K | US$6.38M | 0.11% |
| Alamar Biosciences, Inc. | 300K | US$6.13M | 0.11% |
| Contineum Therapeutics, Inc. | 450K | US$6.07M | 0.10% |
| Ocular Therapeutix, Inc. | 495K | US$4.46M | 0.08% |
| Hemab Therapeutics Holdings, Inc. | 65,000 | US$1.85M | 0.03% |
| Immunome, Inc. | 64,792 | US$1.41M | 0.02% |
| Cyclerion Therapeutics, Inc. | 3,000 | US$9,450 | <0.01% |